Quanqin M. Xie
Changzhou, 213003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Expression of PD-L1 in ovarian cancer and its synergistic antitumor effect with PARP inhibitor.
Journal: Gynecologic oncology
Published: August 27, 2019
Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: August 07, 2017
Serum IL-33 level is a predictor of progression-free survival after chemotherapy.
Journal: Oncotarget
Published: February 03, 2017
Lower Bmi-1 Expression May Predict Longer Survival of Colon Cancer Patients.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: September 13, 2016
Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: July 25, 2016
Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients.
Journal: Pathology oncology research : POR
Published: May 28, 2016
Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis.
Journal: International journal of clinical and experimental pathology
Published: December 04, 2014
Agminated spitz nevi: case report and review of the literature.
Journal: Pediatric dermatology
Published: January 03, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026